4.7 Article

Thrombospondin 1 as a novel biological marker of obesity and metabolic syndrome

Journal

METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 64, Issue 11, Pages 1490-1499

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2015.07.016

Keywords

Thrombospondin 1; Biological marker; Obesity; Diabetes; Metabolic syndrome

Funding

  1. Ministry of Education, Culture, Sports, Science, and Technology of Japan, JSPS KAKENHI [24590719, 15K08634]
  2. Danone Institute of Japan Foundation
  3. JSPS KAKENHI [26893335]
  4. Michigan Center of Diabetes Translational Research (MCDTR) Methods and Measurement Core [P30DK092926]
  5. Grants-in-Aid for Scientific Research [26893335, 24590719, 15K08634] Funding Source: KAKEN

Ask authors/readers for more resources

Context. Thrombospondin 1 (THBS1 or TSP-1) is an adipose-derived matricellular protein, which has recently been highlighted as a potential mediator of insulin resistance and adipose inflammation in obesity. Objective. In this study, we aimed to determine the clinical significance of THBS1 as a novel biological marker of visceral obesity, metabolic syndrome, and diabetes. Methods. The THBS1 mRNA level was quantified with real-time PCR in human adipose tissues obtained from 16 non-obese subjects. The relationships between serum THBS1 level and obesity/diabetes traits as well as the diagnostic components of metabolic syndrome were assessed in 164 normal-weight or overweight/obese subjects (78 males and 86 females; mean age, 50.4; mean BMI, 29.8) with analysis of covariance (ANCOVA) and regression analyses. Results. THBS1 was predominantly expressed in visceral adipose tissues relative to subcutaneous adipose tissues (P < 0.001). The visceral THBS1 expression was positively associated with the body mass index (BMI; gamma(s) = 0.54, P = 0.033). ANCOVA demonstrated that the THBS1 level is associated with abdominal obesity (P < 0.001), hyperglycemia (P = 0.02), and hypertension (P = 0.04). Multivariable regression analysis suggested an association between serum THBS1 and fasting plasma glucose levels. The associations between serum THBS1 levels and obesity/diabetes traits were found preferentially in women (BMI, gamma(s) = 0.30, P = 0.05; FPG, gamma(s) = 0.26, P = 0.016). Subanalyses demonstrated that the association with obesity traits was predominantly found in premenopausal women (BMI, gamma(s) = 0.41, P = 0.007), whereas the association with diabetes traits was predominant in postmenopausal women (HbA1c, gamma(s) = 0.38, P = 0.01). During medical weight reduction treatment, the change in the serum THBS1 level was associated with the change in BMI and HbA1c in pre- and postmenopausal women, respectively. Conclusions. Serum THBS1 is a useful biological marker of obesity and metabolic syndrome in Japanese subjects, particularly in women. THBS1 may act as a critical circulating factor that couples obesity with metabolic syndrome and diabetes in humans. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available